Your browser doesn't support javascript.
loading
CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.
Kudo, Masatoshi; Matilla, Ana; Santoro, Armando; Melero, Ignacio; Gracián, Antonio Cubillo; Acosta-Rivera, Mirelis; Choo, Su-Pin; El-Khoueiry, Anthony B; Kuromatsu, Ryoko; El-Rayes, Bassel; Numata, Kazushi; Itoh, Yoshito; Di Costanzo, Francesco; Crysler, Oxana; Reig, Maria; Shen, Yun; Neely, Jaclyn; Tschaika, Marina; Wisniewski, Tami; Sangro, Bruno.
Afiliação
  • Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan. Electronic address: m-kudo@med.kindai.ac.jp.
  • Matilla A; Servicio de Digestivo, Hospital General Universitario Gregorio Marañón, CIBEREHD, Madrid, Spain.
  • Santoro A; Department of Biomedical Sciences, Humanitas University Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Via Manzoni 56, 20089 Rozzano, Milan, Italy.
  • Melero I; Department of Immunology and Immunotherapy, Clinica Universidad de Navarra and CIBERONC, Pamplona, Spain.
  • Gracián AC; Hospital Universitario HM Sanchinarro, Centro Integral Oncológico Clara Campal (HM CIOCC), Madrid, Spain; Departamento de Ciencias Médicas Clínicas, Facultad de Medicina, Universidad CEU San Pablo, Madrid, Spain.
  • Acosta-Rivera M; Internal Medicine - Hematology & Oncology, Fundacion de Investigacion, San Juan, Puerto Rico.
  • Choo SP; Division of Medical Oncology, National Cancer Center, Singapore.
  • El-Khoueiry AB; Keck School of Medicine, USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Kuromatsu R; Division of Gastroenterology, Kurume University Hospital, Fukuoka, Japan.
  • El-Rayes B; Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, GA, USA.
  • Numata K; Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Itoh Y; Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Di Costanzo F; Department of Medical Oncology, AOU Careggi, Florence, Italy.
  • Crysler O; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Reig M; BCLC Group, Liver Unit, Hospital Clinic de Barcelona, CIBEREHD, Barcelona, Spain.
  • Shen Y; Bristol Myers Squibb, Princeton, NJ, USA.
  • Neely J; Bristol Myers Squibb, Princeton, NJ, USA.
  • Tschaika M; Bristol Myers Squibb, Princeton, NJ, USA.
  • Wisniewski T; Bristol Myers Squibb, Princeton, NJ, USA.
  • Sangro B; Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
J Hepatol ; 75(3): 600-609, 2021 09.
Article em En | MEDLINE | ID: mdl-34051329
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Nivolumabe Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Nivolumabe Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article